The Battle Between Two $1B+ Biotech Unicorns Post author:Sam Post published:November 5, 2017 Post category:BioPharma Two of the top companies in the field are German-based CureVac and U.S.-based Moderna Therapeutics. Source: BioSpace You Might Also Like Seattle's Genoa Pharma Banks $62 Million and Names a New CEO and CSO May 14, 2017 Aclaris Scoops Up St. Louis Startup in Deal Worth Up to $100M August 7, 2017 Endo International To Announce Third-Quarter 2017 Financial Results October 8, 2017